glp 1 cause dizziness and Wegovy: What's the Connection? – Sarah Hormachea TrimRX | Does Wegovy Cause

Retatrutide is an investigational drug that is not FDA-approved

Published in JAMA Ophthalmology in July 2024, the matched cohort study of 16,827 patients found semaglutide users faced a hazard ratio of 4.28 for NAION among diabetic patients and 7.64 among overweight or obese patients, compared with patients on non-GLP-1 medications

the more the GLP1-RA are used, the greater will be the AE-Disease-Burden

Screening will be particularly important for people who are considered overweight, since their restrictive or disordered eating habits are already often overlooked because their weight doesnt reflect the typical look of the disorder

What can I do about it